By developing, manufacturing and marketing products for applied nucleic acid detection technology, GeneReach Biotechnology provides pathogen detection platforms to multiple industries and have introduced them into human health industries.
POCKIT® Central SARS-CoV-2 (orf 1ab) Premix Reagent is an CE-marked in vitro diagnostic molecular assay for qualitative detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) RNA in oro/nasopharyngeal swabs from patients suspected of SARS-CoV-2 infection. This assay is intended for use with POCKIT® Central system.
Application areas
For use with POCKIT Central Nucleic Acid Analyzer
In vitro diagnostic use
Professional use
Features/Strengths
Clinical performance is equivalent to real-time PCR
Easy-to-use, no sample pretreatment
Process up to 8 samples in 85 minutes
Detect prevailing SARS-CoV-2 variants (VOC & VOI)
The company offers OEM/ODM for LDTs and service provider of PCR reagent lyophilization.
